can semaglutide cause acne Treating Scars - Vedas Medical Spa & Wellness | Aesthetic | Cosmetic GLP-1 Medications and Acne: Research

One example is retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, which demonstrated statistically significant weight loss (22.8-24.2%) and metabolic improvements in systolic and diastolic blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, and lipids in a 48-week phase 2 trial, highlighting its potential for future obesity management

[95% CI 0.571.11]

Current GLP-3R peptide research focuses on its interaction with glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor pathways, enabling the study of coordinated multi-receptor signaling and peptide-mediated pathway dynamics

Decrease sugar production in the liver